Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 31.6T | 28.8T | 29.6T | 26.5T |
Cost of revenue | 20.7T | 18.4T | 19.8T | 17.2T |
Gross profit | 10.9T | 10.4T | 9.9T | 9.3T |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 3.1T | 1.9T | 3.0T | 2.6T |
Other operating expenses | 352.5B | -3.5B | 558.3B | 228.2B |
Operating income | 6.1T | 6.9T | 5.3T | 5.1T |
Non operating interest income | ||||
Income | 427.1B | 428.6B | 257.1B | 628.8B |
Expense | 905.8B | 1.0T | 721.7B | 1.1T |
Other income expense | — | — | — | — |
Pretax income | 4.9T | 1.2T | 8.4T | 3.0T |
Tax provision | 979.4B | 400.1B | 1.9T | 706.7B |
Net income | 3.9T | 792.5B | 6.4T | 2.3T |
Basic EPS | 310 | — | — | — |
Diluted EPS | 310 | — | — | — |
Basic average shares | 8.8B | — | — | — |
Diluted average shares | 8.8B | — | — | — |
EBITDA | 5.9T | 3.0T | 9.3T | 4.3T |
Net income from continuing op. | — | — | — | — |
Minority interests | -1.2T | -911.6B | -1.5T | -895.8B |
Preferred stock dividends | 0 | 0 | 0 | 0 |